These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 15985105

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The impact of a worksite migraine intervention program on work productivity, productivity costs, and non-workplace impairment among Spanish postal service employees from an employer perspective.
    Vicente-Herrero T, Burke TA, Laínez MJ.
    Curr Med Res Opin; 2004 Nov; 20(11):1805-14. PubMed ID: 15537481
    [Abstract] [Full Text] [Related]

  • 3. Time to pain freedom and onset of pain relief with rizatriptan 10 mg and prescription usual-care oral medications in the acute treatment of migraine headaches: a multicenter, prospective, open-label, two-attack, crossover study.
    Bell CF, Foley KA, Barlas S, Solomon G, Hu XH.
    Clin Ther; 2006 Jun; 28(6):872-80. PubMed ID: 16860170
    [Abstract] [Full Text] [Related]

  • 4. Patient-reported benefits of rizatriptan compared with usual non-triptan therapy for migraine in a primary care setting.
    Baos V, Serrano A, Torrecilla M, Bertral C, Caloto MT, Nocea G, Gerth WC, I-MAX Study Group.
    Int J Clin Pract; 2003 Nov; 57(9):761-8. PubMed ID: 14686564
    [Abstract] [Full Text] [Related]

  • 5. Long-term efficacy and tolerability of rizatriptan wafers in migraine.
    Cady R, Crawford G, Ahrens S, Hairwassers D, Getson A, Visser WH, Lines C, Rizatriptan-RPD Study Group.
    MedGenMed; 2001 Jun 01; 3(3):1. PubMed ID: 11549974
    [Abstract] [Full Text] [Related]

  • 6. Rizatriptan 10-mg wafer versus usual nontriptan therapy for migraine: analysis of return to function and patient preference.
    Pascual J, García-Moncó C, Roig C, Yusta Izquierdo A, López-Gil A, eMAX Study Group.
    Headache; 2005 Oct 01; 45(9):1140-50. PubMed ID: 16178944
    [Abstract] [Full Text] [Related]

  • 7. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, single-attack study and two open-label, multiple-attack studies.
    Visser WH, Winner P, Strohmaier K, Klipfel M, Peng Y, McCarroll K, Cady R, Lewis D, Nett R, Rizatriptan Protocol 059 and 061 Study Groups.
    Headache; 2004 Oct 01; 44(9):891-9. PubMed ID: 15447698
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Migraine treatment with rizatriptan and non-triptan usual care medications: a pharmacy-based study.
    Cady R, Martin V, Adelman J, Diamond M, Sajjan S, Hu XH.
    Headache; 2004 Oct 01; 44(9):900-7. PubMed ID: 15447699
    [Abstract] [Full Text] [Related]

  • 11. Impact of migraine and migraine therapy on productivity and quality of life.
    Solomon GD, Santanello N.
    Neurology; 2000 Oct 01; 55(9 Suppl 2):S29-35. PubMed ID: 11089517
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Eletriptan in migraine patients reporting unsatisfactory response to rizatriptan.
    Goldstein J, Tiseo PT, Albert KS, Li C, Sikes CR.
    Headache; 2006 Oct 01; 46(7):1142-50. PubMed ID: 16866718
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of rizatriptan for menstrual migraine in an early intervention model: a prospective subgroup analysis of the rizatriptan TAME (Treat A Migraine Early) studies.
    Martin V, Cady R, Mauskop A, Seidman LS, Rodgers A, Hustad CM, Ramsey KE, Skobieranda F.
    Headache; 2008 Feb 01; 48(2):226-35. PubMed ID: 18005144
    [Abstract] [Full Text] [Related]

  • 15. Rizatriptan efficacy in ICHD-II pure menstrual migraine and menstrually related migraine.
    Nett R, Mannix LK, Mueller L, Rodgers A, Hustad CM, Skobieranda F, Ramsey KE.
    Headache; 2008 Sep 01; 48(8):1194-201. PubMed ID: 18422606
    [Abstract] [Full Text] [Related]

  • 16. Company reference estimates for productivity loss due to migraine and productivity gains using rizatriptan 10 mg in Germany.
    Yoon MS, Katsarava Z, Liedert B, Krobot KJ, Diener HC, Limmroth V.
    Int J Clin Pract; 2006 Mar 01; 60(3):295-9. PubMed ID: 16494644
    [Abstract] [Full Text] [Related]

  • 17. Times to pain relief and pain freedom with rizatriptan 10 mg and other oral triptans.
    Ng-Mak DS, Hu XH, Chen Y, Ma L, Solomon G.
    Int J Clin Pract; 2007 Jul 01; 61(7):1091-111. PubMed ID: 17537184
    [Abstract] [Full Text] [Related]

  • 18. Rizatriptan vs. rizatriptan plus trimebutine for the acute treatment of migraine: a double-blind, randomized, cross-over, placebo-controlled study.
    Krymchantowski AV, Filho PF, Bigal ME.
    Cephalalgia; 2006 Jul 01; 26(7):871-4. PubMed ID: 16776704
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics of rizatriptan tablets during and between migraine attacks.
    Cutler NR, Jhee SS, Majumdar AK, McLaughlin D, Brucker MJ, Carides AD, Kramer MS, Matzura-Wolfe D, Reines SA, Goldberg MR.
    Headache; 1999 Apr 01; 39(4):264-9. PubMed ID: 15613223
    [Abstract] [Full Text] [Related]

  • 20. Improvements in health-related quality of life with sumatriptan treatment for migraine.
    Jhingran P, Cady RK, Rubino J, Miller D, Grice RB, Gutterman DL.
    J Fam Pract; 1996 Jan 01; 42(1):36-42. PubMed ID: 8537803
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.